City of Hope Chicago
Locations
Transplant Summary
Overview
The Hematologic Malignancies and Stem Cell Transplant Program at Cancer Treatment Centers of America® (CTCA), Chicago offers patients expertise in diagnosing and treating hematologic diseases using sophisticated technologies and therapies delivered through a personalized approach. The FACT accredited program provides standard-of-care and, when appropriate, advanced medical therapies for hematologic (blood) disorders, including leukemia, non-Hodgkin lymphoma, Hodgkin lymphoma, multiple myeloma and myelodysplastic syndromes, in both an inpatient and outpatient environment. Once in treatment, patients and their families are cared for by a multidisciplinary team of experts and specialists led by a board-certified hematologic oncologist.This center has been performing allogeneic transplants since 1998 and has been an NMDP transplant center since September 2011.
Attending physicians
Adult - Tulio RodriguezTransplants performed
Marrow/PBSC onlyCord blood transplants
Adult onlyOther programs and services
Patients also have access to an array of integrative care services, such as nutrition, naturopathic, psychosocial and spiritual support, as well as other services focused on helping patients manage side effects, recover from treatment and improve quality of life. See https://www.cancercenter.com/locations/chicago for more informationPatient survival information for this center
This center's actual 1-year survival results are above the expected rate for this center*.The survival information we have for this center includes ONLY:- Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2020, 2021, 2022 and
- Who had their transplant at a U.S. transplant center, and
- Who had follow-up information provided by the transplant center for analysis
For this center, we have survival information for 23 patients.The actual 1-year survival of these patients is 82.6%.Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 42.5% and 80%.For help with understanding these statistics, please see Understanding Transplant Outcomes.For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report (Opens in a new tab) at bloodcell.transplant.hrsa.gov.* The expected survival rate for a transplant center can be below, similar to, or above the range listed. This is based on comparing patient survival at all centers that treated patients with similar diseases.
The survival rate cannot tell how you will do with your transplant. Talk to your doctor to understand your prognosis or the likely course of your disease.
Total adult transplants
27
Transplants reported by the centers (from January 1, 2022 to December 31, 2023)
Marrow PBSC Cord blood Total AllogeneicRelated donorMarrow0PBSC8Cord blood0Total8Unrelated donorMarrow0PBSC5Cord blood0Total5Total allogeneicMarrow0PBSC13Cord blood0Total13AutologousMarrowBoth marrow & PBSC 14PBSC—Cord blood—Total14Total combinedMarrowBoth marrow & PBSC 27PBSC—Cord blood0Total27All Diseases
Number of transplants by age reported from January 1, 2022 to December 31st, 2023(includes marrow, PBSC and cord blood)
0-18 19-44 45-64 65+ Total Related 0-18019-44045-64865+0Total8Unrelated 0-18019-44045-64365+2Total5Autologous 0-18019-44445-64565+5Total14Total 0-18019-44445-641665+7Total27Treatments may be similar for diseases within a group. It might be helpful to look at centers that have done transplants for a specific disease and centers that have done transplants for any corresponding broad disease categories.
Centers are not required to report autologous transplants so the numbers might be incomplete.
More information about transplants can be found:
- U.S. Transplant Data by Center (Opens in a new tab) report at blood cell.transplant.hrsa.gov
- List of diseases
Transplant center resources
NMDP patient navigators
Patient navigators can answer your questions about choosing a transplant center and provide support and education to help you throughout your transplant journey.
- Inside the United States: 1 (888) 999-6743
- Outside the United States: 1 (763) 406-3410. (Long distance or international charges may apply.)
Email: patientinfo@nmdp.org
More resources
- Choosing a transplant center
- Preparing for transplant
- Learn about transplant outcomes and treatment decisions (Opens in a new tab)
- Support and resources (including non-English materials)
- U.S. Transplant Data by Center (Opens in a new tab) at blood cell.transplant.hrsa.gov
No survivorship program information is available. Contact the center for information about post-transplant care.